Cellebrite DI Ltd Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
21.1%projected annual EPS growth
Analyst Coverage
7analysts covering
FY Revenue (est.)
$556.7Mnext fiscal year
FY EPS (est.)
$0.55next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release | 12 Nov 2026 |
Monitoring Framework
Key Performance Indicators
Annual Recurring Revenue (ARR) Quarterly493MTarget: 567000000 to 573000000
Subscription Revenue Growth Quarterly2,300.0%Target: 18 to 19 percent ARR growth
Recurring Revenue Dollar-Based Net Retention Rate (NRR) Quarterly11,500.0%
Adjusted EBITDA Margin Quarterly2,390.0%Target: 26 to 27 percent
Research as of 19 Jun 2026